Loading...
Header Logo
Keywords
Last Name
Institution

Professor Karen Irma Barnes

Title[no position]
Institution[no institution name]
Address[no address]
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Sinxadi P, Donini C, Johnstone H, Langdon G, Wiesner L, Allen E, Duparc S, Chalon S, McCarthy JS, Lorch U, Chibale K, Möhrle J, Barnes KI. Safety, tolerability, pharmacokinetics and antimalarial activity of the novel Plasmodium phosphatidylinositol 4-kinase inhibitor MMV390048 in healthy volunteers. Antimicrob Agents Chemother. 2020 Jan 13. PMID: 31932368.
      View in: PubMed
    2. Raman J, Allen E, Workman L, Mabuza A, Swanepoel H, Malatje G, Frean J, Wiesner L, Barnes KI. Safety and tolerability of single low-dose primaquine in a low-intensity transmission area in South Africa: an open-label, randomized controlled trial. Malar J. 2019 Jun 24; 18(1):209. PMID: 31234865.
      View in: PubMed
    3. Kredo T, Mauff K, Workman L, Van der Walt JS, Wiesner L, Smith PJ, Maartens G, Cohen K, Barnes KI. The interaction between artemether-lumefantrine and lopinavir/ritonavir-based antiretroviral therapy in HIV-1 infected patients. BMC Infect Dis. 2016 Jan 27; 16:30. PMID: 26818566.
      View in: PubMed
    4. Silal SP, Little F, Barnes KI, White LJ. Hitting a Moving Target: A Model for Malaria Elimination in the Presence of Population Movement. PLoS One. 2015; 10(12):e0144990. PMID: 26689547.
      View in: PubMed
    5. Silal SP, Little F, Barnes KI, White LJ. Predicting the impact of border control on malaria transmission: a simulated focal screen and treat campaign. Malar J. 2015 Jul 12; 14:268. PMID: 26164675.
      View in: PubMed
    6. Denoeud-Ndam L, Dicko A, Baudin E, Guindo O, Grandesso F, Sagara I, Lasry E, Palma PP, Parra AM, Stepniewska K, Djimde AA, Barnes KI, Doumbo OK, Etard JF. A multi-center, open-label trial to compare the efficacy and pharmacokinetics of Artemether-Lumefantrine in children with severe acute malnutrition versus children without severe acute malnutrition: study protocol for the MAL-NUT study. BMC Infect Dis. 2015 Jun 12; 15:228. PMID: 26068100.
      View in: PubMed
    7. White NJ, Ashley EA, Recht J, Delves MJ, Ruecker A, Smithuis FM, Eziefula AC, Bousema T, Drakeley C, Chotivanich K, Imwong M, Pukrittayakamee S, Prachumsri J, Chu C, Andolina C, Bancone G, Hien TT, Mayxay M, Taylor WR, von Seidlein L, Price RN, Barnes KI, Djimdé A, ter Kuile F, Gosling R, Chen I, Dhorda MJ, Stepniewska K, Guérin P, Woodrow CJ, Dondorp AM, Day NP, Nosten FH. Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria. Malar J. 2014 Dec 09; 13:483. PMID: 25486998.
      View in: PubMed
    8. Zaloumis SG, Tarning J, Krishna S, Price RN, White NJ, Davis TM, McCaw JM, Olliaro P, Maude RJ, Kremsner P, Dondorp A, Gomes M, Barnes K, Simpson JA. Population pharmacokinetics of intravenous artesunate: a pooled analysis of individual data from patients with severe malaria. CPT Pharmacometrics Syst Pharmacol. 2014 Nov 05; 3:e145. PMID: 25372510.
      View in: PubMed
    9. Silal SP, Little F, Barnes KI, White LJ. Towards malaria elimination in Mpumalanga, South Africa: a population-level mathematical modelling approach. Malar J. 2014 Aug 03; 13:297. PMID: 25086861.
      View in: PubMed
    10. Lourens C, Lindegardh N, Barnes KI, Guerin PJ, Sibley CH, White NJ, Tarning J. Benefits of a pharmacology antimalarial reference standard and proficiency testing program provided by the Worldwide Antimalarial Resistance Network (WWARN). Antimicrob Agents Chemother. 2014 Jul; 58(7):3889-94. PMID: 24777099.
      View in: PubMed
    11. Allen EN, Mushi AK, Massawe IS, Vestergaard LS, Lemnge M, Staedke SG, Mehta U, Barnes KI, Chandler CI. How experiences become data: the process of eliciting adverse event, medical history and concomitant medication reports in antimalarial and antiretroviral interaction trials. BMC Med Res Methodol. 2013 Nov 14; 13:140. PMID: 24229315.
      View in: PubMed
    12. Silal SP, Barnes KI, Kok G, Mabuza A, Little F. Exploring the seasonality of reported treated malaria cases in Mpumalanga, South Africa. PLoS One. 2013; 8(10):e76640. PMID: 24204650.
      View in: PubMed
    13. Morris N, Frean J, Baker L, Ukpe IS, Barnes KI, Kruger P, Mabuza A, Raswiswi E, Maharaj R, Blumberg L, Moonasar D. Re-defining the extent of malaria transmission in South Africa: implications for chemoprophylaxis. S Afr Med J. 2013 Oct 02; 103(11):861-4. PMID: 24148174.
      View in: PubMed
    14. Allen EN, Chandler CI, Mandimika N, Pace C, Mehta U, Barnes KI. Evaluating harm associated with anti-malarial drugs: a survey of methods used by clinical researchers to elicit, assess and record participant-reported adverse events and related data. Malar J. 2013 Sep 16; 12:325. PMID: 24041367.
      View in: PubMed
    15. Upke IS, Moonasar D, Raman J, Barnes KI, Baker L, Blumberg L. Case management of malaria: treatment and chemoprophylaxis. S Afr Med J. 2013 Aug 29; 103(10 Pt 2):793-8. PMID: 24079636.
      View in: PubMed
    16. Walubo A, Barnes KI, Kwizera E, Greeff O, Rosenkranz B, Maartens G. Clinical pharmacology becomes a specialty in South Africa. S Afr Med J. 2013 Jan 09; 103(3):150-1. PMID: 23472687.
      View in: PubMed
    17. Svensson E, van der Walt JS, Barnes KI, Cohen K, Kredo T, Huitema A, Nachega JB, Karlsson MO, Denti P. Integration of data from multiple sources for simultaneous modelling analysis: experience from nevirapine population pharmacokinetics. Br J Clin Pharmacol. 2012 Sep; 74(3):465-76. PMID: 22300396.
      View in: PubMed
    18. Moonasar D, Asomugha C, Baker L, Blumberg L, Barnes KI, Maharaj R, Benson F. Preventing disease and saving lives: the malaria season is upon us. S Afr Med J. 2011 Nov 25; 101(12):865-7. PMID: 22273020.
      View in: PubMed
    19. Raman J, Mauff K, Muianga P, Mussa A, Maharaj R, Barnes KI. Five years of antimalarial resistance marker surveillance in Gaza Province, Mozambique, following artemisinin-based combination therapy roll out. PLoS One. 2011; 6(10):e25992. PMID: 22022487.
      View in: PubMed
    20. Kredo T, Mauff K, Van der Walt JS, Wiesner L, Maartens G, Cohen K, Smith P, Barnes KI. Interaction between artemether-lumefantrine and nevirapine-based antiretroviral therapy in HIV-1-infected patients. Antimicrob Agents Chemother. 2011 Dec; 55(12):5616-23. PMID: 21947399.
      View in: PubMed
    21. Tekete MM, Toure S, Fredericks A, Beavogui AH, Sangare CP, Evans A, Smith P, Maiga H, Traore ZI, Doumbo OK, Barnes KI, Djimde AA. Effects of amodiaquine and artesunate on sulphadoxine-pyrimethamine pharmacokinetic parameters in children under five in Mali. Malar J. 2011 Sep 21; 10:275. PMID: 21936885.
      View in: PubMed
    22. Kift EV, Kredo T, Barnes KI. Parenteral artesunate access programme aims at reducing malaria fatality rates in South Africa. S Afr Med J. 2011 Apr; 101(4):240-1. PMID: 21786724.
      View in: PubMed
    23. Lourens C, Watkins WM, Barnes KI, Sibley CH, Guerin PJ, White NJ, Lindegardh N. Implementation of a reference standard and proficiency testing programme by the World Wide Antimalarial Resistance Network (WWARN). Malar J. 2010 Dec 25; 9:375. PMID: 21184684.
      View in: PubMed
    24. Mehta U, Allen E, Barnes KI. Establishing pharmacovigilance programs in resource-limited settings: the example of treating malaria. Expert Rev Clin Pharmacol. 2010 Jul; 3(4):509-25. PMID: 22111680.
      View in: PubMed
    25. Weber IB, Baker L, Mnyaluza J, Matjila MJ, Barnes K, Blumberg L. The burden of imported malaria in Gauteng Province. S Afr Med J. 2010 May 04; 100(5):300-3. PMID: 20460023.
      View in: PubMed
    26. Raman J, Little F, Roper C, Kleinschmidt I, Cassam Y, Maharaj R, Barnes KI. Five years of large-scale dhfr and dhps mutation surveillance following the phased implementation of artesunate plus sulfadoxine-pyrimethamine in Maputo Province, Southern Mozambique. Am J Trop Med Hyg. 2010 May; 82(5):788-94. PMID: 20439956.
      View in: PubMed
    27. Distiller GB, Little F, Barnes KI. Nonlinear mixed effects modeling of gametocyte carriage in patients with uncomplicated malaria. Malar J. 2010 Feb 26; 9:60. PMID: 20187935.
      View in: PubMed
    28. Stepniewska K, Ashley E, Lee SJ, Anstey N, Barnes KI, Binh TQ, D'Alessandro U, Day NP, de Vries PJ, Dorsey G, Guthmann JP, Mayxay M, Newton PN, Olliaro P, Osorio L, Price RN, Rowland M, Smithuis F, Taylor WR, Nosten F, White NJ. In vivo parasitological measures of artemisinin susceptibility. J Infect Dis. 2010 Feb 15; 201(4):570-9. PMID: 20085495.
      View in: PubMed
    29. Barnes KI, Chanda P, Ab Barnabas G. Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia. Malar J. 2009 Oct 12; 8 Suppl 1:S8. PMID: 19818175.
      View in: PubMed
    30. Nyunt MM, Adam I, Kayentao K, van Dijk J, Thuma P, Mauff K, Little F, Cassam Y, Guirou E, Traore B, Doumbo O, Sullivan D, Smith P, Barnes KI. Pharmacokinetics of sulfadoxine and pyrimethamine in intermittent preventive treatment of malaria in pregnancy. Clin Pharmacol Ther. 2010 Feb; 87(2):226-34. PMID: 19776738.
      View in: PubMed
    31. Allen EN, Little F, Camba T, Cassam Y, Raman J, Boulle A, Barnes KI. Efficacy of sulphadoxine-pyrimethamine with or without artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in southern Mozambique: a randomized controlled trial. Malar J. 2009 Jun 26; 8:141. PMID: 19558654.
      View in: PubMed
    32. Pearce RJ, Pota H, Evehe MS, Bâ el-H, Mombo-Ngoma G, Malisa AL, Ord R, Inojosa W, Matondo A, Diallo DA, Mbacham W, van den Broek IV, Swarthout TD, Getachew A, Dejene S, Grobusch MP, Njie F, Dunyo S, Kweku M, Owusu-Agyei S, Chandramohan D, Bonnet M, Guthmann JP, Clarke S, Barnes KI, Streat E, Katokele ST, Uusiku P, Agboghoroma CO, Elegba OY, Cissé B, A-Elbasit IE, Giha HA, Kachur SP, Lynch C, Rwakimari JB, Chanda P, Hawela M, Sharp B, Naidoo I, Roper C. Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria. PLoS Med. 2009 Apr 14; 6(4):e1000055. PMID: 19365539.
      View in: PubMed
    33. Zikusooka CM, McIntyre D, Barnes KI. Should countries implementing an artemisinin-based combination malaria treatment policy also introduce rapid diagnostic tests? Malar J. 2008 Sep 15; 7:176. PMID: 18793410.
      View in: PubMed
    34. Lee SJ, Stepniewska K, Anstey N, Ashley E, Barnes K, Binh TQ, D'Alessandro U, Day NP, de Vries PJ, Dorsey G, Guthmann JP, Mayxay M, Newton P, Nosten F, Olliaro P, Osario L, Pinoges L, Price R, Rowland M, Smithuis F, Taylor R, White NJ. The relationship between the haemoglobin concentration and the haematocrit in Plasmodium falciparum malaria. Malar J. 2008 Aug 02; 7:149. PMID: 18673575.
      View in: PubMed
    35. De Vries TP, Daniels JM, Mulder CW, Groot OA, Wewerinke L, Barnes KI, Bakathir HA, Hassan NA, Van Bortel L, Kriska M, Santoso B, Sanz EJ, Thomas M, Ziganshina LE, Bezemer PD, Van Kan C, Richir MC, Hogerzeil HV. Should medical students learn to develop a personal formulary? An international, multicentre, randomised controlled study. Eur J Clin Pharmacol. 2008 Jun; 64(6):641-6. PMID: 18338161.
      View in: PubMed
    36. Barnes KI, Little F, Mabuza A, Mngomezulu N, Govere J, Durrheim D, Roper C, Watkins B, White NJ. Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria. J Infect Dis. 2008 Jun 01; 197(11):1605-13. PMID: 18471066.
      View in: PubMed
    37. Orrell C, Little F, Smith P, Folb P, Taylor W, Olliaro P, Barnes KI. Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers. Eur J Clin Pharmacol. 2008 Jul; 64(7):683-90. PMID: 18415093.
      View in: PubMed
    38. White NJ, Stepniewska K, Barnes K, Price RN, Simpson J. Simplified antimalarial therapeutic monitoring: using the day-7 drug level? Trends Parasitol. 2008 Apr; 24(4):159-63. PMID: 18353727.
      View in: PubMed
    39. Barnes KI, Watkins WM, White NJ. Antimalarial dosing regimens and drug resistance. Trends Parasitol. 2008 Mar; 24(3):127-34. PMID: 18262470.
      View in: PubMed
    40. Raman J, Sharp B, Kleinschmidt I, Roper C, Streat E, Kelly V, Barnes KI. Differential effect of regional drug pressure on dihydrofolate reductase and dihydropteroate synthetase mutations in southern Mozambique. Am J Trop Med Hyg. 2008 Feb; 78(2):256-61. PMID: 18256426.
      View in: PubMed
    41. Sevene E, Mariano A, Mehta U, Machai M, Dodoo A, Vilardell D, Patel S, Barnes K, Carné X. Spontaneous adverse drug reaction reporting in rural districts of Mozambique. Drug Saf. 2008; 31(10):867-76. PMID: 18759510.
      View in: PubMed
    42. Castillo-Riquelme M, McIntyre D, Barnes K. Household burden of malaria in South Africa and Mozambique: is there a catastrophic impact? Trop Med Int Health. 2008 Jan; 13(1):108-22. PMID: 18291009.
      View in: PubMed
    43. Mehta U, Durrheim DN, Blockman M, Kredo T, Gounden R, Barnes KI. Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational study. Br J Clin Pharmacol. 2008 Mar; 65(3):396-406. PMID: 18070223.
      View in: PubMed
    44. Sibley CH, Barnes KI, Watkins WM, Plowe CV. A network to monitor antimalarial drug resistance: a plan for moving forward. Trends Parasitol. 2008 Jan; 24(1):43-8. PMID: 18042432.
      View in: PubMed
    45. Arens J, Barnes K, Crowley N, Maartens G. Treating AIDS-associated cerebral toxoplasmosis - pyrimethamine plus sulfadiazine compared with cotrimoxazole, and outcome with adjunctive glucocorticoids. S Afr Med J. 2007 Oct; 97(10):956-8. PMID: 18000578.
      View in: PubMed
    46. Barnes KI, Lindegardh N, Ogundahunsi O, Olliaro P, Plowe CV, Randrianarivelojosia M, Gbotosho GO, Watkins WM, Sibley CH, White NJ. World Antimalarial Resistance Network (WARN) IV: clinical pharmacology. Malar J. 2007 Sep 06; 6:122. PMID: 17822537.
      View in: PubMed
    47. Price RN, Dorsey G, Ashley EA, Barnes KI, Baird JK, d'Alessandro U, Guerin PJ, Laufer MK, Naidoo I, Nosten F, Olliaro P, Plowe CV, Ringwald P, Sibley CH, Stepniewska K, White NJ. World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs. Malar J. 2007 Sep 06; 6:119. PMID: 17822532.
      View in: PubMed
    48. Sibley CH, Barnes KI, Plowe CV. The rationale and plan for creating a World Antimalarial Resistance Network (WARN). Malar J. 2007 Sep 06; 6:118. PMID: 17822531.
      View in: PubMed
    49. Mehta U, Durrheim DN, Blumberg L, Donohue S, Hansford F, Mabuza A, Kruger P, Gumede JK, Immelman E, Sánchez Canal A, Hugo JJ, Swart G, Barnes KI. Malaria deaths as sentinel events to monitor healthcare delivery and antimalarial drug safety. Trop Med Int Health. 2007 May; 12(5):617-28. PMID: 17445129.
      View in: PubMed
    50. Sharp BL, Kleinschmidt I, Streat E, Maharaj R, Barnes KI, Durrheim DN, Ridl FC, Morris N, Seocharan I, Kunene S, LA Grange JJ, Mthembu JD, Maartens F, Martin CL, Barreto A. Seven years of regional malaria control collaboration--Mozambique, South Africa, and Swaziland. Am J Trop Med Hyg. 2007 Jan; 76(1):42-7. PMID: 17255227.
      View in: PubMed
    51. Barnes KI. Rolling back malaria in Africa. S Afr Med J. 2007 Jan; 97(1):36-7. PMID: 17378278.
      View in: PubMed
    52. Mehta U, Durrheim D, Mabuza A, Blumberg L, Allen E, Barnes KI. Malaria pharmacovigilance in Africa: lessons from a pilot project in Mpumalanga Province, South Africa. Drug Saf. 2007; 30(10):899-910. PMID: 17867727.
      View in: PubMed
    53. Barnes KI, Little F, Smith PJ, Evans A, Watkins WM, White NJ. Sulfadoxine-pyrimethamine pharmacokinetics in malaria: pediatric dosing implications. Clin Pharmacol Ther. 2006 Dec; 80(6):582-96. PMID: 17178260.
      View in: PubMed
    54. Newton PN, Barnes KI, Smith PJ, Evans AC, Chierakul W, Ruangveerayuth R, White NJ. The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria. Eur J Clin Pharmacol. 2006 Dec; 62(12):1003-9. PMID: 17089111.
      View in: PubMed
    55. Simpson JA, Agbenyega T, Barnes KI, Di Perri G, Folb P, Gomes M, Krishna S, Krudsood S, Looareesuwan S, Mansor S, McIlleron H, Miller R, Molyneux M, Mwenechanya J, Navaratnam V, Nosten F, Olliaro P, Pang L, Ribeiro I, Tembo M, van Vugt M, Ward S, Weerasuriya K, Win K, White NJ. Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients. PLoS Med. 2006 Nov; 3(11):e444. PMID: 17132053.
      View in: PubMed
    56. Attaran A, Barnes KI, Bate R, Binka F, d'Alessandro U, Fanello CI, Garrett L, Mutabingwa TK, Roberts D, Sibley CH, Talisuna A, Van Geertruyden JP, Watkins WM. The World Bank: false financial and statistical accounts and medical malpractice in malaria treatment. Lancet. 2006 Jul 15; 368(9531):247-52. PMID: 16844495.
      View in: PubMed
    57. Barnes KI, Durrheim DN, Little F, Jackson A, Mehta U, Allen E, Dlamini SS, Tsoka J, Bredenkamp B, Mthembu DJ, White NJ, Sharp BL. Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. PLoS Med. 2005 Nov; 2(11):e330. PMID: 16187798.
      View in: PubMed
    58. Malenga G, Palmer A, Staedke S, Kazadi W, Mutabingwa T, Ansah E, Barnes KI, Whitty CJ. Antimalarial treatment with artemisinin combination therapy in Africa. BMJ. 2005 Oct 01; 331(7519):706-7. PMID: 16195260.
      View in: PubMed
    59. Dzinjalamala FK, Macheso A, Kublin JG, Taylor TE, Barnes KI, Molyneux ME, Plowe CV, Smith PJ. Association between the pharmacokinetics and in vivo therapeutic efficacy of sulfadoxine-pyrimethamine in Malawian children. Antimicrob Agents Chemother. 2005 Sep; 49(9):3601-6. PMID: 16127028.
      View in: PubMed
    60. Barnes KI, White NJ. Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum. Acta Trop. 2005 Jun; 94(3):230-40. PMID: 15878154.
      View in: PubMed
    61. Pearce R, Malisa A, Kachur SP, Barnes K, Sharp B, Roper C. Reduced variation around drug-resistant dhfr alleles in African Plasmodium falciparum. Mol Biol Evol. 2005 Sep; 22(9):1834-44. PMID: 15917494.
      View in: PubMed
    62. Mehta U, Barnes KI, Kathard H, Vugt Mv, Durrheim D. Comment on: Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether. Trans R Soc Trop Med Hyg. 2005 Apr; 99(4):313-4; author reply 314-5. PMID: 15708390.
      View in: PubMed
    63. Dzinjalamala FK, Macheso A, Kublin JG, Taylor TE, Barnes KI, Molyneux ME, Plowe CV, Smith PJ. Blood folate concentrations and in vivo sulfadoxine-pyrimethamine failure in Malawian children with uncomplicated Plasmodium falciparum malaria. Am J Trop Med Hyg. 2005 Mar; 72(3):267-72. PMID: 15772319.
      View in: PubMed
    64. Stepniewska K, Taylor WR, Mayxay M, Price R, Smithuis F, Guthmann JP, Barnes K, Myint HY, Adjuik M, Olliaro P, Pukrittayakamee S, Looareesuwan S, Hien TT, Farrar J, Nosten F, Day NP, White NJ. In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up. Antimicrob Agents Chemother. 2004 Nov; 48(11):4271-80. PMID: 15504852.
      View in: PubMed
    65. Muheki C, McIntyre D, Barnes KI. Artemisinin-based combination therapy reduces expenditure on malaria treatment in KwaZulu Natal, South Africa. Trop Med Int Health. 2004 Sep; 9(9):959-66. PMID: 15361108.
      View in: PubMed
    66. Barnes KI, Mwenechanya J, Tembo M, McIlleron H, Folb PI, Ribeiro I, Little F, Gomes M, Molyneux ME. Efficacy of rectal artesunate compared with parenteral quinine in initial treatment of moderately severe malaria in African children and adults: a randomised study. Lancet. 2004 May 15; 363(9421):1598-605. PMID: 15145633.
      View in: PubMed
    67. Attaran A, Barnes KI, Curtis C, d'Alessandro U, Fanello CI, Galinski MR, Kokwaro G, Looareesuwan S, Makanga M, Mutabingwa TK, Talisuna A, Trape JF, Watkins WM. WHO, the Global Fund, and medical malpractice in malaria treatment. Lancet. 2004 Jan 17; 363(9404):237-40. PMID: 14738799.
      View in: PubMed
    68. Barnes KI, Folb PI. Measuring resistance to malaria. S Afr Med J. 2004 Jan; 94(1):36-7. PMID: 14971228.
      View in: PubMed
    69. Wilkins JJ, Folb PI, Valentine N, Barnes KI. An economic comparison of chloroquine and sulfadoxine-pyrimethamine as first-line treatment for malaria in South Africa: development of a model for estimating recurrent direct costs. Trans R Soc Trop Med Hyg. 2002 Jan-Feb; 96(1):85-90. PMID: 11926003.
      View in: PubMed
    70. Bredenkamp BL, Sharp BL, Mthembu SD, Durrheim DN, Barnes KI. Failure of sulphadoxine-pyrimethamine in treating Plasmodium falciparum malaria in KwaZulu-Natal. S Afr Med J. 2001 Nov; 91(11):970, 972. PMID: 11847918.
      View in: PubMed
    71. Durrheim DN, Sharp BL, Barnes K. Sentinel malaria surveillance--more than a research tool. S Afr Med J. 2001 Nov; 91(11):968-70. PMID: 11847917.
      View in: PubMed
    72. Kachur SP, Abdulla S, Barnes K, Mshinda H, Durrheim D, Kitua A, Bloland P. Re.: Complex, and large, trials of pragmatic malaria interventions. Trop Med Int Health. 2001 Apr; 6(4):324-5. PMID: 11348524.
      View in: PubMed
    73. Fivelman QL, Walden JC, Smith PJ, Folb PI, Barnes KI. The effect of artesunate combined with standard antimalarials against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg. 1999 Jul-Aug; 93(4):429-32. PMID: 10674097.
      View in: PubMed
    Barnes's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description